NEFH and amyotrophic lateral sclerosis: Studies have shown that both NFL and NFH levels are highly elevated in ALS and correlate with measures of disease progression in ALS [19,20,21], leading to measures of NFL and NFH now being incorporated into clinical trial designs in ALS as a secondary outcome measure [22,23].